Yisheng Biotechnology (01061.HK) 2022 Annual Results Conference
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.
Read more
Comment
Sign in to view/post comments
The official account of Essexbio Bio
A biopharmaceutical company focusing on the research, development, production and sales of the genetically engineered drug rb-bFGF (recombinant bovine basic fibroblast growth factor)
9280Followers
12KVisitors
Follow